Pharma’s reputation has climbed during COVID-19 pandemic, study finds
Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings
Read More
Tag: FutureBrand Index
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
